Skip to main content
. 2023 Jan 11;16:71–77. doi: 10.2147/CCID.S391893

Figure 1.

Figure 1

Skin sensitivity at baseline, Day 15 and Day 30. M89PF significantly (p<0.0001) reduced skin sensitivity as early as Day 15.